Abstract
Background: Essential oils (EOs) are aromatic, volatile and concentrated hydrophobic liquids extracted from plant material. EOs are also called as ethereal oils, volatile oils or aetherolea. EOs also play a crucial role in plant defence and signalling processes. They are mostly used in perfumes, cosmetics, soaps and other products for flavouring food, drinks, adding scents to incense and household cleaning products. EOs have a long medicinal history.
Methods: Reported research literature and online contents related to the use of EOs for their biochemical pharmacological applications in cancer prevention therapy were reviewed. The most relevant and updated citations were included in this review.
Results: This review elaborates the various types of EOs, their biochemical characteristics, and pharmacology. Medicinal benefits of essential oil products range from various skin treatments to different types of therapies for cancer and are dependent entirely on historical backgrounds of use of EOs for these properties. EOs have antimicrobial, anticancer, antioxidant, antiparasitical, insecticidal, anti-inflammatory, viricidal, fungicidal, wound healing, antihypertensive, analgesic properties and other medicinal properties. The efficiency of EOs in medical treatments and treatment of cancers are these days a subject of interest in most countries.
Conclusion: This review elaborated the potentials of EOs in regulating cancer cell growth and have explored the probable EOs that can be used in drug development.
Keywords: Essential oils, biomedical effects, natural prevention, anticancer, apoptosis, hydrophobic liquids.
Anti-Cancer Agents in Medicinal Chemistry
Title:Biochemical and Pharmacological Applications of Essential Oils in Human Health Especially in Cancer Prevention
Volume: 18 Issue: 13
Author(s): Pir Mohammad Ishfaq, Archana Shukla, Satyaprakash Beraiya, Swati Tripathi*Siddhartha K. Mishra*
Affiliation:
- Amity Institute of Microbial Technology, Amity University, Noida - 201313 (U.P.),India
- Cancer Biology Laboratory, School of Biological Sciences (Zoology), Dr. Harisingh Gour Central University, Sagar - 470003 (M.P.),India
Keywords: Essential oils, biomedical effects, natural prevention, anticancer, apoptosis, hydrophobic liquids.
Abstract: Background: Essential oils (EOs) are aromatic, volatile and concentrated hydrophobic liquids extracted from plant material. EOs are also called as ethereal oils, volatile oils or aetherolea. EOs also play a crucial role in plant defence and signalling processes. They are mostly used in perfumes, cosmetics, soaps and other products for flavouring food, drinks, adding scents to incense and household cleaning products. EOs have a long medicinal history.
Methods: Reported research literature and online contents related to the use of EOs for their biochemical pharmacological applications in cancer prevention therapy were reviewed. The most relevant and updated citations were included in this review.
Results: This review elaborates the various types of EOs, their biochemical characteristics, and pharmacology. Medicinal benefits of essential oil products range from various skin treatments to different types of therapies for cancer and are dependent entirely on historical backgrounds of use of EOs for these properties. EOs have antimicrobial, anticancer, antioxidant, antiparasitical, insecticidal, anti-inflammatory, viricidal, fungicidal, wound healing, antihypertensive, analgesic properties and other medicinal properties. The efficiency of EOs in medical treatments and treatment of cancers are these days a subject of interest in most countries.
Conclusion: This review elaborated the potentials of EOs in regulating cancer cell growth and have explored the probable EOs that can be used in drug development.
Export Options
About this article
Cite this article as:
Ishfaq Mohammad Pir , Shukla Archana , Beraiya Satyaprakash , Tripathi Swati *, Mishra K. Siddhartha *, Biochemical and Pharmacological Applications of Essential Oils in Human Health Especially in Cancer Prevention, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (13) . https://dx.doi.org/10.2174/1871520618666181002130240
DOI https://dx.doi.org/10.2174/1871520618666181002130240 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Biomarkers Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
Endocrine, Metabolic & Immune Disorders - Drug Targets Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Current Medicinal Chemistry Vitamin D and Vitamin D Analogs in Cancer Treatment
Current Drug Targets An In Silico Investigation of Potential EGFR Inhibitors for the Clinical Treatment of Colorectal Cancer
Current Topics in Medicinal Chemistry Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.
Reviews on Recent Clinical Trials Managing Expectations in the Transition to Proof of Concept Studies
Reviews on Recent Clinical Trials How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design Nucleoprotein-Derived and Unbound Ribonucleosides: Bioactivity and Potential Applications
Current Pharmaceutical Design Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward
Anti-Cancer Agents in Medicinal Chemistry Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line
Drug Metabolism Letters Targeting Ion Channels in Cancer: A Novel Frontier in Antineoplastic Therapy
Current Medicinal Chemistry The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma
Current Gene Therapy Predicating Candidate Cancer-Associated Genes in the Human Signaling Network Using Centrality
Current Bioinformatics Update of QSAR & Docking Studies of the GSK-3 Inhibitors
Current Bioinformatics Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents
Current Medicinal Chemistry Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Current Pharmaceutical Design